Contractor Support

Bristol-Myers Squibb works with contractors and suppliers to ensure the highest level of quality, expertise, experience, and fit with our operating culture. We expect our contractors and suppliers to comply with all legal and regulatory requirements for the workplace, including health and safety, diversity, and human rights.

Contract Employees

Bristol-Myers Squibb uses agencies that provide temporary employees to perform a wide range of services, and our EHS staff is developing guidance that addresses key issues, such as training. EHS personnel also evaluate contracts for maintenance, mailroom, security, cafeteria, and other services to make sure that they cover EHS performance issues. A guideline for developing a contractor safety program is published on the company’s internal EHS website.

Pharmaceutical Supply Chain Initiative

Bristol-Myers Squibb joined other pharmaceutical companies to form the Pharmaceutical Supply Chain Initiative (PSCI) in 2005. The initiative is designed to leverage efficiencies, reduce risk, and implement responsible practices in the pharmaceutical supply chain. In 2007, the PSCI released the Pharmaceutical Industry Principles for Responsible Supply Chain Management (“the Principles”). These Principles address five areas of responsible business practices throughout the pharmaceutical industry's supply chain: ethics, labor, health and safety, environment and related management systems. The benefits are expected to include increased efficiency by standardizing expectations and implementation schemes; reduced potential liabilities by improving workplace conditions; and reduced risk of business interruption due to substandard social or environmental practices.

Bristol-Myers Squibb's third-party manufacturer EHS assessment process is aligned with the Principles, and the company is currently evaluating implementation options for the other areas covered by the Principles. For more information, please visit the PSCI web site.

Contractor Evaluations

Bristol-Myers Squibb may conduct a Quality or EHS evaluation of a contractor or supplier. Determining whether an evaluation is warranted depends on the extent of Bristol-Myers Squibb’s involvement in the operations of the contractor or supplier, as well as the nature of such operations.

In addition, we have developed an EHS questionnaire that may be sent to third-party manufacturers that manufacture, finish or package Bristol-Myers Squibb products, active pharmaceutical ingredients (APIs), intermediates or other critical non-commodity materials.

Based on the results of the questionnaire, we may conduct a site evaluation. EHS works closely with sourcing staff to determine the priorities for the site evaluation. The evaluation team will make recommendations and then develop and track an action plan for the contractor. The questionnaire or site visit may be repeated periodically, based on risk.

During 2006, Bristol-Myers Squibb conducted 32 questionnaire reviews with 25 on-site visits. Bristol-Myers Squibb conducted 39 questionnaire reviews with 35 on-site visits during 2007.

Through initiatives such as this, Bristol-Myers Squibb benefits by:

Sending a clear message to our contractors that EHS is important
Supporting our ability to recognize strong performers among our contractors
Strengthening our ability to encourage EHS performance among our partners
Receiving feedback on best practices and opportunities for continued partnership and dialogue with contractors

Last updated June 25, 2008 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

Contractor Information

Student Information

Members of the Community